ducts associated with the gut, as well as SMCs around the 2 . Methods bladder, trachea and bronchi are all derived from the lateral mesoderm [8] . In contrast, the majority of the vascular 2 .1. Tissue samples and cell culture SMCs are considered to be either locally recruited from the primordium, pro-epicardial organ or neural crest after Human primary SMCs were obtained from iliac artery invasion by endothelial cells, or from circulating by enzymatic dispersion (collagenase / elastinase / soybean progenitor cells [9, 10] . Also, trans-differentiation of endotrypsin inhibitor: Worthington Biochem., Lakewood, NJ, thelial cells to SMCs has been reported [11] .
USA). Cells were cultured in Opti-MEM I Reduced Serum SMC specific proteins can be used as markers of Medium supplemented with 15% fetal calf serum (Life development or differentiation if their expression is speTechnologies, Paisley, UK). Human tissues (umbilical cific for a particular phenotype or stage of SMCs or if cord / iliac / uterine artery, aorta, uterus, gut, colon, ileum, isoforms are characteristic of specific SMC lineages.
stomach, skeletal muscle, liver, brain, heart) and mouse Smoothelin has both properties. It is a marker protein for tissues (uterus, prostate, lung, oesophagus, stomach, colon, the end-stage of SMC differentiation since it has been iliac artery, carotid artery, aorta and heart) were isolated, found only in contractile SMCs [12, 13] . Furthermore, the immediately frozen and stored at 280 8C until use. The two adult isoforms of smoothelin are expressed in a tissue use of human and animal tissues was approved by the specific manner: a 59 kDa isoform, smoothelin-A, in ethical board of the university. Cells and tissues were visceral and urogenital tissues, and a 110 kDa isoform, screened for the presence of smoothelin by indirect fluoressmoothelin-B, in vascular tissues (previously described as cent antibody technique. Procedures were carried out as 94 kDa protein) [14, 15] . Transient synthesis of a third described previously [12] . smoothelin isoform has been detected in embryonic striated muscle cells in chicken [16] .
2 .2. Antibody generation SMCs can also be grouped according to the nature of their contraction. Tonic and phasic SMCs can be disTo generate a mouse monoclonal antibody directed tinguished. Tonic SMCs, which are primarily found in against human smoothelin, mice were immunized with blood vessels, have a slow rate of force activation and recombinant human smoothelin-A. The fusion procedure relaxation, lower maximum speeds of shortening and good and cloning of the hybridomas were performed according force maintenance. Phasic SMCs, in contrast, show a high to standard protocols [22] . Isotyping of the monoclonal rate of force activation and relaxation, high maximum antibody was done with the Mouse Mab Isotyping kit speeds of shortening and poor force maintenance [17] . The according to the manufacturer's instructions (Life Techlatter are mainly found in SMCs in the gastrointestinal nologies). Smooth muscle specificity of the monoclonal tract. These physiological differences in distinct SMC antibody was determined by screening cells and tissues by populations are reflected in proteins that make up the Western blotting and indirect fluorescence staining as cyto-architectural structures of the SMCs [3, 18] . Studies in described previously [12] . The epitope recognized by the chicken embryos revealed that during development, antibody was mapped using deletion expression constructs smoothelin-B is not only found in vascular but also in of the smoothelin-A cDNA. Several fragments were cloned visceral SMCs of the digestive tract. When the embryonic in frame in the pRSET vector and proteins were produced visceral SMCs change their contractile profile from tonic in E. coli of the M15 strain (Fig. 1a) and analyzed on to phasic (around hatching), smoothelin-B is replaced by Western blot as described in the next section. the smoothelin-A isoform [16] . This expression pattern not only makes smoothelin a valuable marker for SMC differentiation, but is also indicative of a function of 2 .3. Protein gel electrophoresis and Western blotting smoothelin in SMC contraction.
Previously, we have demonstrated that smoothelin is Cryostat sections (20 per sample, 10 mm) of freshly encoded by a single copy gene, located on chromosome frozen tissues were collected, washed with phosphate 22q12.3 and we and others have provided a rough map of buffered saline (PBS) and centrifuged for 5 min at the structure of the gene [19] [20] [21] . In this study, Northern 12 0003g. After centrifugation, the pellet was subjected to blotting proved that there are two transcripts mediating the a Triton X-100 extraction step. Cells were resuspended in generation of the two major smoothelin isoforms. The 1% Triton X-100, 5 mM ethylenediaminotetraacetic acid cloning and characterization of vascular SMC-specific disodium salt dihydrate (Merck, Darmstadt, Germany), 0.4 smoothelin-B cDNA and the smoothelin gene are demM phenylmethylsulfonyl fluoride (Merck) in PBS, pH scribed. Alternative splicing was found to introduce varia-7.4 and extracted for 5 min on ice. After centrifugation for tions in the calponin homology domain (CH-domain) of 5 min at 12 0003g, the pellet was washed in 1 ml PBS. the smoothelins, which probably mediates actin binding.
After a final centrifugation step (5 min, 12 0003g), the Promoter reporter assays show that alternative promoters preparation was dissolved by boiling for 4 min in sample are used to produce smoothelin-A or smoothelin-B mRNA.
buffer [23] , with 2.3% sodium dodecylsulfate (SDS) and 5% b-mercaptoethanol (Bio-Rad Laboratories, Hercules, separation, the proteins were stained with Page Blue 83 CA, USA).
(BDH Chemicals, Poole, UK) or subjected to Western For SDS-polyacrylamide gel electrophoresis (SDSblotting on a nitrocellulose membrane (Schleicher & PAGE) on a Mini Protean II Electrophoresis Cell (Bio-Rad Schull, BA85: Dassel, Germany). To estimate the amount Laboratories), 7.5-10% polyacrylamide slab gels containof protein transferred, blots were stained with Ponceau red. ing 0.1% SDS were used [23] . After electrophoretic
The monoclonal antibody C6G, directed against smoothelin, was used at a 1:5 dilution. Antigen-antibody the putative protein were carried out using BLAST algointeraction was visualized by chemiluminescence (ECL kit, rithms [26] and protein structure program PHD [27, 28] . Amersham, Buckinghamshire, UK). screened with a P-labeled smoothelin-A cDNA probe. Total RNA of vascular tissues (umbilical cord artery, Two positive clones were purified to homogeneity. One of aorta, primary cell cultures of iliac artery) and non-vascuthe clones contained the complete coding region of the lar tissues (gut, colon, stomach, skeletal muscle) was smoothelin gene. In addition, 6 kb 59 flanking sequence extracted with LiCl [24] . Ten micrograms of total RNA was present. This clone was subcloned into pUC19 and was separated on a 1% agarose formaldehyde denaturing exon-containing subclones were identified by colony hygel [24] . RNA was transferred to nitrocellulose (S&S bridization with cDNA fragments. A complete restriction BA83) and hybridized to smoothelin cDNA probes accord-32 map of the cosmid clone was constructed and exons and ing to standard procedures. Probes were P-labeled by their flanking regions were sequenced. Sequencing was random priming (Life Technologies) [25] . Filters were carried out according to Sanger et al. [29] using an Applied washed in decreasing SSC (NaCl / NaCitrate) concentraBiosystems AmpliTaq cycling kit for automatic sequencing tions with a final concentration of 0.13 SSC / 0.1% SDS.
in an Applied Biosystems 310 (Perkin Elmer, Norwalk, Alternative splicing was investigated by reverse tran-USA). Searches for sequence homology were performed scription-polymerase chain reaction (RT-PCR). Five through GenBank / EMBL databases. Intronic sequences micrograms of total vascular RNA extracted from mouse were screened with HEXON software which allows detissues were subjected to oligo(d)T primed reverse trantection of potential additional exons [30] . scription. Sets of primers that covered the smoothelin-A cDNA were used for PCR. Length of the PCR-generated fragments was compared with those generated by PCR of 2 .7. Primer extension analysis the smoothelin-A cDNA. Expression of detected alternative splice variants (all located in the CH-domain) was
The smoothelin-A transcription start site was determined further investigated by RT-PCR with the following primby primer extension using a primer extension system from ers: forward 59GTCGACATCCAGAACTTCCTCC; rePromega (Madison, WI, USA). Briefly, 10 mg RNA verse 59CGCAGGTGGTTGTACAGCGA. The PCR conextracted from human ileum with Trizol (Life Techditions applied were: 2 min initial denaturation at 94 8C, 30 nologies) according to the manufacturer's instructions was s at 94 8C, 30 s at 54 8C, 30 s at 72 8C (35 cycles) with a reverse transcribed with SuperscriptII Reverse Transcripfinal extension of 5 min using an MWG AG Biotech tase (Life Technologies) for 1 h at 42 8C using the 32 Primus 96plus thermal cycler. PCR products were anafollowing [g-P] end-labeled primer: lyzed on a 2% agarose gel.
59GTGAATGTGGTCTTCATACTG. Annealing of the primer was done at 60 8C for 1 h. Primer extension products were analyzed on a gel containing 8% acryl-2 .5. Cloning of the human cDNA for smoothelin-B amide, 7 M urea and 13 TBE buffer. Labeled wX174 HinfI DNA markers were loaded on the gel to determine RNA was isolated from human iliac artery smooth the size of the generated fragments. muscle by Trizol extraction according to the manufacturer's instructions. Concentration and quality of RNA were 32 evaluated by Northern blot analysis using a P-labeled 2 .8. Smoothelin promoter reporter assays smoothelin-A cDNA [25] .
Rapid amplification of cDNA ends (59RACE) was To investigate the putative promoters of the smoothelin applied to investigate the possibility of a 59 extension of gene, smoothelin reporter constructs were made based on the smoothelin-A mRNA. Based on sequences of the 59 transcription start sites as determined by 59RACE and part of the smoothelin-A cDNA, the following primers primer extension assays (Fig. 6) . Two smoothelin-A were used in a 59RACE system (Life Technologies):
promoter fragments containing 1613 or 370 bp of the 59 59GCATGGCTGAAGCTGGTGAC and flanking region, exon 10 and 60 bp of intron 10 were 59GTGAATGTGGTCTTCATACTG. PCR fragments were cloned into the pGL3-basic vector (Promega) using SstI generated and cloned. Colonies were screened with a and HindIII sites. The 1613 bp fragment was subcloned in genomic fragment containing the sequence from 2200 to the pbGal-basic vector (Clontech Laboratories, Palo Alto, 160 of the smoothelin-A cDNA. Clones containing cDNA CA, USA) using SphI sites. inserts were mapped by restriction digestion and seFive smoothelin-B promoter fragments of increasing quenced. Sequence comparison and structural analysis of length were cloned in the pGL3-basic vector. The fragment sizes varied from 84 to 3372 bp of the region upstream of transcript of |3000 nt hybridizing with the smoothelin-A the smoothelin-B transcription start site. The first cDNA, whereas in visceral smooth muscle tissues the smoothelin-B exon and 28 bp of the first intron were major hybridizing transcript was only about 1600 nt ( [14, 19] . An RT-PCR screen of RNA 2 days after transfection with a luciferase assay system extracted from vascular tissues did not reveal an alternative according to the provided instructions (Promega) in a splicing corresponding to the difference in size between Biocounter M1500 luminometer (Lumac, Landgraaf, The the two smoothelin transcripts. Hence a 59 extension of the Netherlands). Measurements were carried out for 10 s after smoothelin-A mRNA was investigated by a 59 RACE a 2 s delay. Co-transfection of a TK-promoter driven procedure using RNA of a primary culture of human iliac renilla luciferase vector for internal normalization influartery SMCs. A discrete band of 1700 bp was generated in enced the behavior of the smoothelin promoter constructs three independent experiments. This product was cloned tested, as previously described for a-SMA promoter assays and sequenced. Sequences of several clones were aligned [32] . Instead, luciferase activity of a control pGL3-promotand compared with the sequence of the smoothelin gene er vector containing an SV40 promoter upstream of the (see below). The 3000 nt transcript in iliac artery SMC luciferase gene was used to correct for variations, after cultures and vascular tissues hybridized with the 59 RACE subtracting the baseline activity of the pGL3-basic vector.
fragment. In visceral tissues, hybridization of the 59RACE Variation in lysate recovery was corrected for by determinproduct with the 3000 nt (but not the 1600 nt) mRNA was ing protein concentration of the samples. All constructs only seen after long exposure (Fig. 2) . were transfected in duplicate in three independent experiThe smoothelin-B sequence contains a CH-domain as ments. Cells transfected with the b-galactosidase reporter does smoothelin-A. The RT-PCR screen mentioned above construct were fixed with 0.25% glutaraldehyde after 52 h.
revealed two alternative splicings in this CH-domain. Staining solution containing 0.1 mg X-Gal was applied for These alternative splicings were found in smoothelin-A as 18 h at 37 8C.
well as smoothelin-B mRNA. The three variants are defined by the presence or absence of exon 20 ( tions indicate a molecular weight of 100 kDa, which corroborates with the 110 kDa protein found on Western A monoclonal antibody, C6G, was generated against blots. Tertiary structure analysis suggests that the N-termirecombinant human smoothelin-A. The antibody of the nal 130 amino acids of the smoothelin-B isoforms adopt an IgG1 subclass reacted specifically with smooth muscle a-helical configuration. tissue. The epitope of the antibody, which recognizes both Smoothelin-B2 cDNA has an ORF of 2745 bp, coding smoothelin-A and smoothelin-B, is located within a stretch for 915 amino acids producing a protein of 99 kDa. of 30 amino acids in exon 11 (amino acids 56-86 of Smoothelin-B3 cDNA only contains the 59 70 bp of exon smoothelin-A, 512-542 of smoothelin-B; see Fig. 1a ).
20. The ORF of the A3 / B3 variants continues through Western blotting showed that the principal product recogexon 21 causing the translational stop to be at the same nized by C6G in visceral smooth muscle tissues was the 59 position as in smoothelin-B1, with an insertion of 23 kDa smoothelin-A, whereas in vascular tissues the major amino acids (Fig. 4) . The homology of the CH-domain to product identified was the 110 kDa smoothelin-B (Fig. 1b) .
the actin-binding domain of members of the spectrin In non-smooth muscle tissues like liver, brain or heart, no family is 45%, irrespective of the splice variant. Alterimmunoreactive product was detected. C6G reacted with native splicing of only the 59 part of exon 20 inserts an smooth muscle tissues of human, goat and rabbit but not extra 23 amino acids homologous to the CH-domain. Thus, with dog, pig and mouse. C6G reacted relatively strongly the C-terminus of smoothelin-B3 contains a part of this with smoothelin-B compared with the previously described domain in duplicate. Expression of the different alternative R4A antibody.
splice variants of smoothelin-B and -A showed no coherent tissue specificity (Fig. 5) , although prostate, lung and 3 .2. Cloning and characterization of human smoothelinoesophagus seemed to express less of the A1 variant B cDNAs compared to vascular tissues. All three splice variants were found in investigated smooth muscle tissues, with the Northern blotting analysis of cultured SMCs of human exception of prostate that did not express the A3 variant. In iliac artery, aorta and umbilical cord artery revealed a most of the smooth muscle tissues tested, the expression level of the B3 and A3 variants was considerably lower [20] . The structure of the human gene closely resembles compared to the other two variants. The human the mouse gene structure [33] . The first two exons are smoothelin-B1, B2 and B3 sequences have been deposited separated from the other exons by a 5 kb intron. Exon 10 is in GenBank under accession numbers Y13492, AY061971 the largest exon comprising 526 bp. In the middle of this and AY061972.
exon the transcription start site of smoothelin-A is located (Fig. 3) . The exon-intron boundaries match the GT-AG 3 .3. Cloning and analysis of the human smoothelin gene splice recognition sequence. Between exons 16 and 17, a 50 bp TAAA repeat has been found. The vascular specific A human cosmid library was screened with smoothelinpart of the smoothelin-B cDNA sequence is coded for by A cDNA probes and two cosmids containing the full size the exons 1 through 9 and the 59 half of exon 10 (Fig. 3) . smoothelin gene were selected. Twenty-one exons have
The 39 half of exon 10 and the remaining 10 exons are been positioned by hybridization with cDNA fragments coding for both smoothelin isoforms. The sequences of the and sequencing (Fig. 3) . As such, the present map of the exons have been deposited in GenBank under accession gene represents a refining of the previously reported one numbers AF115551-AF115570. Screening of intronic sequences for internal exons with HEXON software regenerated, this shows that the smoothelin-A and -B cDNA vealed additional potential exons located in introns 11 and have completely different 59 ends. These 59 ends are 19. These 'alternative' exons are conserved between separated by approximately 10 kb of genomic sequence, mouse and human, contain correct splice sites and their indicating that two different transcription start sites may be addition to the mRNA would not disturb the reading used. Sequences directly upstream of the putative tranframe. However, these exons have not been found in any scription initiation sites have been screened for promoter / mature smoothelin mRNAs so far.
enhancer elements (Fig. 6b,c) . The putative promoter regions of neither smoothelin-A nor smoothelin-B contain 3 .4. Smoothelin transcription start site mapping and a TATA-box, but a number of promoter / enhancer elepromoter reporter assays ments have been identified. Amongst them are CArG(like) boxes, E-boxes, AP-2 and Sp-1 sites, a TGF-b-control Primer extension of RNA extracted from human ileum element and GATA boxes. Comparison between human with a smoothelin specific primer produced a fragment of and mouse putative promoter sequences of smoothelin-B 83 nt (Fig. 6a) . Together with the 59RACE results which revealed a high degree (66%) of homology for about 700 revealed that in vascular tissues a much larger transcript is bp upstream of the transcription initiation site. The putative smoothelin-A promoter, which also contains exons of the smoothelin-B-specific part, showed an even higher degree of conservation (73%). Intronic sequences were generally as conserved as exon sequences [33] . Promoter reporter assays indicated that the region upstream of the first smoothelin-B exon has promoter activity (Fig. 7a) . A minimal promoter construct containing 84 bp of the region upstream of the transcription start site was able to drive luciferase expression, albeit at low levels. Increasing the size of the promoter fragments up to 750 bp resulted in a higher expression. Larger promoter fragments of 1097 and 1616 bp in contrast gave a lower luciferase activity. The highest activity was conferred by a construct containing 3372 bp of the promoter. Apart from the minimal promoter, all constructs that were tested showed considerable specificity for SMC.
A smoothelin-A promoter fragment of 370 bp was not able to drive luciferase expression in any of the cell types tested. The minimal promoter for the smoothelin-A transcript therefore has to include elements more upstream of this region. A more extensive analysis of the smoothelin-A (Fig. 7a) . Because of the variation, sequence of the primer used for primer extension analysis is underlined. the same fragment was cloned upstream of another reporter estimated from the cDNA open reading frame is 100 kDa which is in good agreement with the approximately 110 kDa MW observed in Western blotting analyses (small inter-species differences have been found, for instance the pig smoothelin-B is 115 kDa) [37] . Computer assisted structure analysis of the putative amino acid sequence revealed potential a-helical structures. The most prominent one is a 130 amino acid domain at the N-terminus of smoothelin-B. Such a domain may be involved in the formation of filamentous structures or may have a function in coiled-coil interactions with other molecules as described for many cytoskeletal and cytoskeleton-associated proteins [40] . At the C-terminus, a CH-domain with homology to the actin-binding domain of the spectrin family is present in smoothelin-B (as in smoothelin-A). Both smoothelins contain only one CH-domain, which binds directly to actin (unpublished data; Niessen / Gabbiani). In contrast, similar single CH-domains, found in other actin-associated proteins such as SM22a and calponin appear not to bind actin directly [41] . Alternative cells were identified, confirming that this region of the splicing of exon 20 can generate three different CHsmoothelin gene exerts promoter activity (Fig. 7b) .
domains in smoothelin-A and -B. Two of these alternative splicings in smoothelin-B have been described previously [21] . However, we show that a third alternative splicing 4 . Discussion can occur in all smooth muscle tissues except prostate and that these alternative splicings occur in both smoothelin-A The contractile apparatus of SMCs is constructed around and smoothelin-B mRNA. The lack of a tissue specific SMC-specific isoforms of actin and myosin proteins.
expression of any of these variants implies that these Smooth muscle-specific proteins such as calponin, SM22a alternatively spliced actin-binding sites may have little and h-caldesmon are associated with a-SMA or myosin physiological significance. Apparently, neither the a-heli- [18, [34] [35] [36] . The function of these proteins is still unclear.
cal structure at the N-terminal nor the alternative splicing Smoothelins are a recent addition to the group of actinproducts of the C-terminus of both smoothelins influence associated SMC-specific proteins. They share a number of the subcellular distribution of smoothelin and more parcharacteristics with calponin and SM22a such as the ticularly its co-localization with actin. Therefore, our presence of a CH-domain and transient expression in the present data indicate that the smoothelin isoforms and their primitive heart during embryogenesis [16] . However, splice-variants perform, at least in part, similar functions in smoothelin expression is restricted to contractile SMCs visceral and vascular SMCs. The influence of the alterwhereas calponin and SM22a are also expressed in less native splicings on the affinity of the different smoothelin differentiated SMCs. As such, smoothelin has been used as isoforms for actin is currently under investigation. a marker for the differentiated phenotype of SMCs [37, 38] .
In situ hybridization and radiation hybrid analysis has Previously, we have characterized smoothelin as a shown that smoothelins are encoded by a single copy gene structural protein, specific for contractile smooth muscle [19] . Consequently, three options were at hand to explain tissues. A smoothelin cDNA cloned from visceral smooth the occurrence of the smoothelin-B isoform in vascular muscle tissue was demonstrated to code for the 59 kDa smooth muscle tissue: (1) extensive post-translational smoothelin-A [12] . However, Western blotting of smooth modification of smoothelin-A; (2) alternative splicing; (3) muscle tissues in several species revealed that two isoalternative promoters. forms of smoothelin exist [14, 15] . In addition to the If post-translational modification were responsible for 59 kDa smoothelin-A in visceral tissues, we found an the increase in molecular weight, the two isoforms of immunoreactive product of 110 kDa in vascular tissues.
smoothelin would be translational products of the same Analysis of a variety of smooth muscle tissues indicated mRNA. However, Northern blotting revealed two mRNAs that this protein, designated smoothelin-B, is specific for both hybridizing to the smoothelin-A cDNA. A 1600 nt contractile vascular SMCs in adults [14, 37] .
transcript was found in visceral tissues, whereas a 3000 nt Here we present evidence that in humans, like in mice mRNA was found in vascular SMCs. The sizes of these [39] , this smoothelin-B isoform is translated from a 3000 two mRNAs correspond with the two protein isoforms of nt mRNA whereas smoothelin-A is translated from a 1600 smoothelin. The weak 3000 nt band observed in visceral nt mRNA. The molecular weight of smoothelin-B as tissues is most likely due to the presence of blood vessels, although different expression ratios of the two major control. The lower luciferase activity of the constructs isoforms in various smooth muscle tissues cannot be containing 1097 and 1616 bp of the smoothelin-B promotcompletely ruled out. Thus, post-translational modification er compared with the construct containing 750 bp indicates cannot be responsible for the increase in MW of the that two or more repressor elements may be present in the vascular isoform.
region between 2750 and 21616 bp. Interestingly, this Alternative splicing was investigated by RT-PCR with reduction of promoter activity only occurs in SMCs. primers enclosing the splice sites in the smoothelin-A Strong SMC-specific enhancers appear to be present mRNA. This revealed the presence of an additional exon between 21616 and 23372 bp of the smoothelin-B (20) or a part of this exon in the mature vascular mRNA of promoter as evidenced by a large increase in promoter both smoothelin-A and -B. Addition of this exon modifies activity in SMCs of the 3372 bp smoothelin-B promoter the C-terminus of the proteins, making them two amino construct. Numerous cis-acting elements can be identified acids shorter. In chicken embryonic striated muscle cells in this region. The functionality of these elements however and in some prostate tumor cell lines, corresponding remains to be determined by footprinting, gel mobility alternatively spliced mRNAs have been found [16, 42] . The shift assays and mutational analysis. minor decrease in the ORF caused by the alternative The use of alternative promoters sets the smoothelins splicing of exon 20 dismisses this mechanism as the origin apart from the other described SMC-specific genes. It of smoothelins-A and -B. In conclusion, alternative splicapparently enables SMCs to regulate smoothelin expresing does not generate the smoothelin-A and -B isoforms sion in a strict tissue specific fashion. Physically separated but it provides diversity in the smoothelin CH-domain, promoters provide a way to respond differentially to encoded by exons 18-21. extracellular signals (e.g. hormones). Comparison of the Consequently, alternative promoters are the remaining two promoters may reveal important insight in gene option for the generation of the smoothelin-A and -B regulation in different SMC populations. isoforms. This is not common, although a number of these promoter systems have been described [43] . Primer extension and 59RACE experiments provided evidence for two A cknowledgements independent transcription start sites. The sequences located 59 of both transcription start sites contain a number of
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